| A Follow-up Study on Safety and Tolerability of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease (NCT01807338) | Newron Sweden AB | 2011-08-01 |
| Expressive Writing for Individuals With Parkinson's Disease and Their Caregivers (NCT02217735) | Virginia Commonwealth University | 2011-08-01 |
| Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's Disease (NCT01544465) | Northwestern University | 2011-08-01 |
| Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism (NCT01759888) | Chang Gung Memorial Hospital | 2011-08-01 |
| The Effects of Sertraline on Depression in Parkinson's Disease (NCT01437189) | Zhejiang University | 2011-08-01 |
| Automated Parkinson's Disease (PD) Motor Symptom Assessment for Deep Brain Stimulation (DBS) Programming (NCT01429220) | Great Lakes NeuroTechnologies Inc. | 2011-08-01 |
| Agricultural Health Study Follow-up (NCT01399411) | National Institute of Environmental Health Sciences (NIEHS) | 2011-07-05 |
| Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study) (NCT01397422) | Adamas Pharmaceuticals, Inc. | 2011-07-01 |
| Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease (NCT01427517) | University of Minnesota | 2011-07-01 |
| Molecular Analysis of Human Neural Stem Cells (NCT01329926) | NeuroGeneration | 2011-06-30 |
| Efficacy Study of Amantadine to Treat Gait Dysfunction and Freezing in Parkinson's Disease (NCT01652534) | Northwestern University | 2011-06-01 |
| The Effect of Rasagiline on Cognition in Parkinson's Disease (NCT01382342) | Brown University | 2011-06-01 |
| Rehabilitation of Everyday Memory Impairment in Parkinson Disease: A Pilot Study (NCT01469741) | Washington University School of Medicine | 2011-06-01 |
| Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease (NCT02034357) | University of Miami | 2011-06-01 |
| PharmacoMRI of Parkinson Disease (NCT01528592) | Northwestern University | 2011-06-01 |
| Resistance Versus Balance Training in Parkinson's Disease (NCT02253563) | University of Kiel | 2011-06-01 |
| Dual Task Practice in Parkinson's Disease (NCT01375413) | KU Leuven | 2011-06-01 |
| Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Disease Study (NCT01352819) | Abbott Medical Devices | 2011-05-01 |
| Comparison of the Incidence of Dyskinesia in Parkinson's Disease Who Were Treated With Amantadine or Dopamine Agonist (NCT01338662) | Seoul National University Hospital | 2011-05-01 |
| PRISM Registry: Pseudobulbar Affect Registry Series (NCT01366027) | Avanir Pharmaceuticals | 2011-05-01 |
| Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor Fluctuations (NCT01766258) | Orion Corporation, Orion Pharma | 2011-05-01 |
| Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's Disease (NCT01504178) | University Hospital, Toulouse | 2011-05-01 |
| Tele-diagnostics for Remote Parkinson's Monitoring (NCT01356056) | Great Lakes NeuroTechnologies Inc. | 2011-05-01 |
| Ketogenic Diets for Symptoms of Parkinson's Disease (NCT01364545) | University of Oxford | 2011-05-01 |
| Effectiveness Study of Occupational Therapy in Parkinson's Disease (NCT01336127) | Radboud University Medical Center | 2011-04-01 |
| Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations (NCT01338896) | UCB Pharma | 2011-04-01 |
| The Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic Therapy (NCT01313819) | Seoul National University Hospital | 2011-04-01 |
| ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease (NCT01336088) | Addex Pharma S.A. | 2011-04-01 |
| Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients. (NCT01227655) | Bial - Portela C S.A. | 2011-03-01 |
| Study of Dysarthria, Swallowing Disorders and Respiratory in Parkinson's Disease (NCT02627664) | University Hospital, Lille | 2011-03-01 |
| Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension (NCT01316666) | Vanderbilt University Medical Center | 2011-03-01 |
| Pioglitazone in Early Parkinson's Disease (NCT01280123) | University of Rochester | 2011-03-01 |
| Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon (NCT01568073) | Bial - Portela C S.A. | 2011-03-01 |
| COPE-Co-morbidities, Parkinson's Disease and Exercise (NCT01361724) | Oregon Health and Science University | 2011-03-01 |
| Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off (NCT01283594) | Biotie Therapies Inc. | 2011-03-01 |
| A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402) (NCT01294800) | Merck Sharp & Dohme LLC | 2011-02-25 |
| Evaluation of the Safety and Efficacy of Bilateral Subthalamic Nucleus (SNT) Radiosurgery in Idiopathic Severe Parkinson's Disease Fulfilling Inclusion Criteria for STN Deep Brain Stimulation and Presenting With a Contraindication to Intracerebral Electrode Implantation. (NCT01284699) | Assistance Publique Hopitaux De Marseille | 2011-02-04 |
| Managing Changes in Life After Deep Brain Stimulation for Parkinson's Disease (NCT01681641) | University of Aarhus | 2011-02-01 |
| Oxidative Stress and Apoptosis of Energy Metabolism by Deferiprone From the Circulating Lymphocytes (NCT02880033) | University Hospital, Lille | 2011-02-01 |
| Comparing Different Levodopa/Carbidopa/Entacapone Treatment Regimens (NCT01296464) | Orion Corporation, Orion Pharma | 2011-02-01 |
| Combined STN/SNr-DBS for the Treatment of Refractory Gait Disorders in Parkinson's Disease (NCT01355835) | University Hospital Tuebingen | 2011-02-01 |
| Optimization of fMRI for the Study of Basal Ganglia Activation in Parkinson's Disease (NCT01429909) | University Hospital, Clermont-Ferrand | 2011-02-01 |
| Prospective Study to Compare Results of STN-DBS Between Early Treated and Late-treated PD Patient (NCT01274832) | A.O. Ospedale Papa Giovanni XXIII | 2011-02-01 |
| Treatments for Insomnia in Patients With Parkinson's Disease (NCT01489982) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2011-01-01 |
| Biofeedback to Ameliorate Freezing of Gait (NCT01259635) | Tel-Aviv Sourasky Medical Center | 2011-01-01 |
| Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations in Korea (NCT01268891) | H. Lundbeck A/S | 2011-01-01 |
| Cognitive Decline in Non-demented PD (NCT01340885) | Oregon Health and Science University | 2011-01-01 |
| A Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease Patients (NCT01229332) | NeuroDerm Ltd. | 2011-01-01 |
| Long Term Follow-Up Study for rAAV-GAD Treated Subjects (NCT01301573) | Neurologix, Inc. | 2011-01-01 |
| Comparison of Two Rehabilitation Programs in Patients With Mild to Moderate Parkinson's Disease. (NCT02797496) | Assistance Publique - Hôpitaux de Paris | 2010-12-01 |
| Feasibility Study to Evaluate Deep Brain Stimulation (DBS) Settings for the Treatment of Parkinson's Disease (NCT01230151) | Intelect Medical, Inc. | 2010-12-01 |
| Mapping and Manipulating the Emotional Territories of the Basal Ganglia in PD Patients (NCT01267409) | Hadassah Medical Organization | 2010-12-01 |
| The Effect of Methylphenidate on Non-motor Symptoms and Postural Control in Parkinson's Disease. (NCT01244269) | Laval University | 2010-12-01 |
| Dementia Registry for Parkinson's Disease (NCT01251094) | China Medical University Hospital | 2010-11-01 |
| Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE) (NCT01270711) | Pfizer | 2010-11-01 |
| Analysis of the Enteric Nervous System Using Colonic Biopsies (NCT01353183) | Nantes University Hospital | 2010-11-01 |
| Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD) (NCT01060878) | Phytopharm | 2010-11-01 |
| Evaluation of the Effect of Repetitive Transcranial Magnetic Stimulation in Pain Perception in Parkinson's Disease (NCT01275573) | University Hospital, Toulouse | 2010-10-01 |
| Exercise and Cognitive Training in Parkinson's Disease (NCT01156714) | VA Office of Research and Development | 2010-10-01 |
| Evaluation of a Diet in Patients With Senile Dementia (NCT01192529) | Vegenat, S.A. | 2010-10-01 |
| Robotic Locomotor Experience Applied to Parkinson's Disease (NCT01302184) | Azienda Ospedaliero Universitaria Maggiore della Carita | 2010-10-01 |
| Nicotine Treatment of Impulsivity in Parkinson's Disease (NCT01216904) | University of Vermont | 2010-10-01 |
| The Effect of Exercise Training on Gait and Quality of Life in Parkinson's Disease (NCT01701128) | Laval University | 2010-10-01 |
| Computer-Based Balance Training for People With Parkinson's Disease (NCT01162226) | University of California, San Francisco | 2010-09-01 |
| Decrease in Sense of Smell and Associated Cognitive Decline in Parkinson's Disease (NCT01572142) | University of Michigan | 2010-08-01 |
| Balance Training in Parkinson's Disease Using the Wii Balance Board (NCT01228851) | Shirley Ryan AbilityLab | 2010-08-01 |
| The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission Tomography (NCT01824056) | Chang Gung Memorial Hospital | 2010-08-01 |
| Local Field Potentials Recorded From Deep Brain Stimulating (DBS) Electrodes (NCT01427530) | University of Minnesota | 2010-08-01 |
| Effect of Deep Brain Stimulation (DBS) on Sleep Architecture in Patients With Movement Disorders (NCT01169324) | University of Alabama at Birmingham | 2010-07-15 |
| Deep Brain Stimulation (DBS) For Parkinson's Disease: Caudal Zona Incerta Versus Subthalamic Nucleus (NCT00888095) | Charite University, Berlin, Germany | 2010-07-01 |
| Motor Performance in Parkinson's Disease After High Intensive Exercise or Deep Brain Stimulation (NCT01446549) | University of Copenhagen | 2010-07-01 |
| Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study (NCT01174810) | University College, London | 2010-07-01 |
| Cognitive Rehabilitation in Parkinson's Disease (NCT01085968) | VA Office of Research and Development | 2010-07-01 |
| Facial Expression Recognition and Mirror Neurons in Parkinson's Disease (NCT01315405) | University Hospital, Clermont-Ferrand | 2010-07-01 |
| A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects (NCT01171313) | XenoPort, Inc. | 2010-07-01 |
| Parkinson's Disease, Diagnostic Observations (PADDO) (NCT01249768) | Radboud University Medical Center | 2010-07-01 |
| A Study of Safety and Tolerability of Fipamezole in Adult Subjects With Parkinson's Disease Who Are Receiving Levodopa (NCT01140841) | Bausch Health Americas, Inc. | 2010-06-01 |
| Barriers to Mental Healthcare Utilization in Parkinson's Disease (NCT01167608) | Rutgers, The State University of New Jersey | 2010-06-01 |
| A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease (NCT01176240) | Chelsea Therapeutics | 2010-06-01 |
| rTMS for Motor and Mood Symptoms of Parkinson's Disease (NCT01080794) | Beth Israel Deaconess Medical Center | 2010-05-01 |
| Relaxation Guided Imagery for Treatment of Parkinson's Disease (NCT01151111) | Rambam Health Care Campus | 2010-05-01 |
| A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066 (NCT01130493) | Impax Laboratories, LLC | 2010-05-01 |
| Imaging Biomarkers of Progression of Mobility Impairment in Parkinson Disease (NCT01106976) | VA Office of Research and Development | 2010-05-01 |
| 18F-DTBZ for l Diagnosis of Parkinson's Disease and Monitoring the Severity of Disease by VMAT2 PET Imaging (NCT01283347) | Chang Gung Memorial Hospital | 2010-05-01 |
| Glucose Tolerance in Patients With an Idiopathic Parkinson's Disease (NCT01114321) | University Hospital, Clermont-Ferrand | 2010-05-01 |
| Nucleipark:High Field MR Imaging (7T and 3T) of the Brainstem, the Deep Nuclei and Their Connections in the Parkinsonian Syndromes. Applications to Prognosis, Pathophysiology and Improvement of Therapeutic Strategies (NCT01085253) | Institut National de la Santé Et de la Recherche Médicale, France | 2010-04-06 |
| Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects (NCT01113320) | Newron Pharmaceuticals SPA | 2010-04-01 |
| Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611 (NCT01103011) | NeuroDerm Ltd. | 2010-04-01 |
| An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease (NCT01096186) | Impax Laboratories, LLC | 2010-03-01 |
| Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn (NCT01055379) | Lundbeck Italia S.p.A. | 2010-03-01 |
| Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment (NCT02101190) | Bial - Portela C S.A. | 2010-03-01 |
| Italian Validation of the Revised MDS-Unified Parkinson's Disease Rating Scale (NCT01092936) | Fondazione Neureca | 2010-03-01 |
| Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's Disease (NCT02243982) | Fundacion Clinic per a la Recerca Biomédica | 2010-03-01 |
| A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET) (NCT01503944) | Avid Radiopharmaceuticals | 2010-03-01 |
| Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia (NCT01092065) | Novartis | 2010-03-01 |
| Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease (NCT01066442) | Bioprojet | 2010-03-01 |
| 7T MRS in Parkinson's Disease (NCT01237210) | University of Minnesota | 2010-02-01 |
| Prognostic Value of FP-CIT-SPECT in Parkinson´s Disease (NCT01038310) | Universität des Saarlandes | 2010-01-01 |
| Validation of Dyskinesia Rating Scales (NCT01071395) | Rush University Medical Center | 2010-01-01 |
| Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500 (NCT01058291) | Kyowa Kirin Co., Ltd. | 2010-01-01 |